Almudena Pardo

发表

The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II)

J. Pérez-García, A. Llombart-Cussac, J. Cortés, 2020, International journal of environmental research and public health.

The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”

A. Llombart-Cussac, A. Malfettone, M. Sampayo-Cordero, 2021, Frontiers in Molecular Biosciences.